Cargando…
Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study
INTRODUCTION: Congestive heart failure (CHF) causes significant morbidity and mortality. It is an epidemic, and costs are escalating. CHF is a chronic disease whose trajectory includes stable phases, periods of decompensation, and finally palliation. Health services and medical therapies must match...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255353/ https://www.ncbi.nlm.nih.gov/pubmed/37305115 http://dx.doi.org/10.3389/fmed.2023.1059735 |
_version_ | 1785056850848251904 |
---|---|
author | Iyngkaran, Pupalan Hanna, Fahad Andrew, Sharon Horowitz, John David Battersby, Malcolm De Courten, Maximilian Pangratius |
author_facet | Iyngkaran, Pupalan Hanna, Fahad Andrew, Sharon Horowitz, John David Battersby, Malcolm De Courten, Maximilian Pangratius |
author_sort | Iyngkaran, Pupalan |
collection | PubMed |
description | INTRODUCTION: Congestive heart failure (CHF) causes significant morbidity and mortality. It is an epidemic, and costs are escalating. CHF is a chronic disease whose trajectory includes stable phases, periods of decompensation, and finally palliation. Health services and medical therapies must match the various patient needs. Chronic disease self-management (CDSM) programmes that are patient-focused, identify problems and set actionable goals that appear as a logical, cost-friendly method to navigate patient journeys. There have been challenges in standardising and implementing CHF programmes. METHODS AND ANALYSIS: SELFMAN-HF is a prospective, observational study to evaluate the feasibility and validity of the SCRinHF tool, a one-page self-management and readmission risk prediction tool for CHF, with an established, comprehensive CDSM tool. Eligible patients will have CHF with left ventricular ejection fraction <40% and commenced sodium glucose co-transporter-2 inhibitors (SGLT2-i) within 6 months of recruitment. The primary endpoint is the 80% concordance in readmission risk predicted by the SCRinHF tool. The study will recruit >40 patients and is expected to last 18 months. ETHICS AND DISSEMINATION: This study has been approved by the St Vincent’s ethics committee (approval no. LRR 177/21). All participants will complete a written informed consent prior to enrolment in the study. The study results will be disseminated widely via local and international health conferences and peer-reviewed publications. |
format | Online Article Text |
id | pubmed-10255353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102553532023-06-10 Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study Iyngkaran, Pupalan Hanna, Fahad Andrew, Sharon Horowitz, John David Battersby, Malcolm De Courten, Maximilian Pangratius Front Med (Lausanne) Medicine INTRODUCTION: Congestive heart failure (CHF) causes significant morbidity and mortality. It is an epidemic, and costs are escalating. CHF is a chronic disease whose trajectory includes stable phases, periods of decompensation, and finally palliation. Health services and medical therapies must match the various patient needs. Chronic disease self-management (CDSM) programmes that are patient-focused, identify problems and set actionable goals that appear as a logical, cost-friendly method to navigate patient journeys. There have been challenges in standardising and implementing CHF programmes. METHODS AND ANALYSIS: SELFMAN-HF is a prospective, observational study to evaluate the feasibility and validity of the SCRinHF tool, a one-page self-management and readmission risk prediction tool for CHF, with an established, comprehensive CDSM tool. Eligible patients will have CHF with left ventricular ejection fraction <40% and commenced sodium glucose co-transporter-2 inhibitors (SGLT2-i) within 6 months of recruitment. The primary endpoint is the 80% concordance in readmission risk predicted by the SCRinHF tool. The study will recruit >40 patients and is expected to last 18 months. ETHICS AND DISSEMINATION: This study has been approved by the St Vincent’s ethics committee (approval no. LRR 177/21). All participants will complete a written informed consent prior to enrolment in the study. The study results will be disseminated widely via local and international health conferences and peer-reviewed publications. Frontiers Media S.A. 2023-05-12 /pmc/articles/PMC10255353/ /pubmed/37305115 http://dx.doi.org/10.3389/fmed.2023.1059735 Text en Copyright © 2023 Iyngkaran, Hanna, Andrew, Horowitz, Battersby and De Courten. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Iyngkaran, Pupalan Hanna, Fahad Andrew, Sharon Horowitz, John David Battersby, Malcolm De Courten, Maximilian Pangratius Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study |
title | Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study |
title_full | Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study |
title_fullStr | Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study |
title_full_unstemmed | Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study |
title_short | Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study |
title_sort | comparison of short and long forms of the flinders program of chronic disease self-management for participants starting sglt-2 inhibitors for congestive heart failure (selfman-hf): protocol for a prospective, observational study |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255353/ https://www.ncbi.nlm.nih.gov/pubmed/37305115 http://dx.doi.org/10.3389/fmed.2023.1059735 |
work_keys_str_mv | AT iyngkaranpupalan comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy AT hannafahad comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy AT andrewsharon comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy AT horowitzjohndavid comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy AT battersbymalcolm comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy AT decourtenmaximilianpangratius comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy |